Finance

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion

Apr 28, 2025 - 17:31
 0
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
Read More

Tags:

Previous Article

Trump's Fed feud: Why interest rates won't budge anytime soon

Next Article

Is British American Tobacco Stock a Long-Term Buy?

Related Posts

Analyst Says Tesla (TSLA) Valuation Still ‘Incredibly Rich’ as Chinese Companies ‘Eat’ Its Market Share

Analyst Says Tesla (TSLA) Valuation Still ‘Incredibly R...

Apr 27, 2025  0

Here’s Why Madison Mid Cap Fund Sold Its Stake in Armstrong World Industries (AWI)

Here’s Why Madison Mid Cap Fund Sold Its Stake in Armst...

Apr 24, 2025  0

Is Nvidia an Undervalued Growth Stock or a Falling Knife?

Is Nvidia an Undervalued Growth Stock or a Falling Knife?

Apr 27, 2025  0